Denovonedsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-10-16
Share capital
5,000.00 PLN
Activity description

Denovoned is a company that specializes in accelerating drug discovery through its expertise in computational medicinal chemistry.

Registered address
Plac Bankowy 2, 00-095 Warszawa, Poland
Electronic delivery address
AE:PL-85081-61333-WVJAR-13

Financials

Revenue history

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 89 days late).

  • 202512/07/2026
  • 202430/06/2025
  • 202313/07/2024
  • 202215/07/2023
  • 202112/10/2022
  • 202015/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Website technology

Analytics and marketing
  • Google Analytics

Authorized Representatives

Dariusz Michał Ekonomiukage 46 – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
98$1,323.6198%
Others
2$27.012%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

Name
GenomedS.A.
Read-GeneS.A.
Orphinic ScientificS.A.
Proper Medical Writingsp. z o.o.
Medicofarma BiotechS.A.
Zawamedsp. z o.o.
Stenocoatsp. z o.o.
NanovelosS.A.
Spektrinosp. z o.o.
Detoxedsp. z o.o.

FAQ

Last updated: 2026-07-14